Subscribe to RSS
DOI: 10.1055/s-2004-832818
Nickel-Catalyzed Cross-Coupling Reactions of 4-Mesylcoumarins with Aryl Halides: Facile Synthesis of 4-Substituted Coumarins
Publication History
Publication Date:
24 September 2004 (online)
Abstract
A new and efficient nickel-catalyzed cross-coupling reaction between 4-mesylcoumarins and aryl halides was developed to give a number of 4-arylcoumarins in good yield under mild conditions. Unlike the previously reported coupling examples, this new method allows the direct cross-coupling of 4-mesylcoumarins with aryl- or vinyl halides in the NiCl2(PPh3)2/PPh3/Zn/toluene system. This has greatly facilitated the synthesis of biologically useful 4-substituted coumarins.
Key words
coumarin - aryl halide - nickel-catalyzed - homocoupling - cross-coupling
-
1a
Soine TO. J. Pharm. Sci. 1964, 53: 231 -
1b
Chen CH.Fox JL. Proc. Int. Conf. Lasers 1987, 995 -
1c
Edelson RL. Sci. Am. 1988, August: 68 -
1d
Dini A.Ramundo E.Saturnino P.Scimone A.Stagno d’Alcontres I. Boll. Soc. Ital. Biol. Sper. 1992, 68: 453 -
1e
Hoult JR.Paya M. Gen. Pharmacol. 1996, 27: 713 -
1f
Rocha L.Marston A.Kaplan M.Stoeckli-Evans H.Thull U.Testa B.Hostettmann K. Phytochemistry 1994, 36: 1381 -
1g
Levine C.Hiasa H.Marians KJ. Biochim. Biophys. Acta 1998, 29: 1400 -
1h
Vlietinck AJ.De Bruyne T.Apers S.Pieters LA. Planta Med. 1998, 64: 97 -
1i
Murakami A.Gao G.Omura M.Yano M.Ito C.Furukawa H.Takahashi D.Koshimizu K.Ohigashi H. Bioorg. Med. Chem. Lett. 2000, 10: 59 -
1j
Raboin J.-C.Beley M.Kirsch G. Tetrahedron Lett. 2000, 41: 1175 - For reviews, see:
-
2a
Egan D.Okennedy R.Moran E.Cox D.Prosser E.Thornes RD. Drug Metab. Rev. 1990, 22: 503 -
2b
Pineo GF.Hull RD. Drug Safety 1993, 9: 263 -
2c
Murray RDH. Nat. Prod. Rep. 1995, 12: 477 -
2d
Trivedi KN.Rao SSM.Mistry SV.Desai SM. J. Indian Chem. Soc. 2001, 78: 579 -
3a
Awasthi AK.Tewari RS. Synthesis 1986, 1061 -
3b
Sato K.Inour S.Kobayashi T.Ota T.Tazaki M. J. Chem. Soc., Perkin Trans. 1 1987, 1753 -
3c
Desouza MD.Joshi V. Indian J. Heterocycl. Chem. 1993, 3: 93 -
3d
Ivanova DI.Eremin SV.Shvets VI. Tetrahedron 1996, 52: 9581 -
3e
Lee YR.Kim BS.Wang HC. Tetrahedron 1998, 54: 12215 -
3f
De la Hoz A.Moreno A.Vazquez E. Synlett 1999, 608 -
3g
Yavari I.Adib M.Hojabri L. Tetrahedron 2001, 57: 7537 -
3h
Gonzalez-Gomez JC.Santana L.Uriarte E. Synthesis 2002, 43 -
3i
Bose DS.Rudradas AP.Babu MH. Tetrahedron Lett. 2002, 43: 9195 -
3j
Song AM.Wang XB.Lam KS. Tetrahedron Lett. 2003, 44: 1755 -
3k
Kaye PT.Musa MA. Synth. Commun. 2003, 33: 1755 -
3l
Pave G.Chalard P.Viaud-Massuard MC. Synlett 2003, 987 -
3m
Fringuelli F.Piermatti O.Pizzo F. Synthesis 2003, 2331 -
3n
Selles P.Mueller U. Org. Lett. 2004, 6: 277 -
3o
Kontogiorgis CA.Hadjipavlou-Litina DJ. Bioorg. Med. Chem. Lett. 2004, 14: 611 - 4
Kadnikov DV.Larock RC. Org. Lett. 2000, 2: 3643 - 5
Boland GM.Donnelly DMX.Finet J.-P.Rea MD. J. Chem. Soc., Perkin Trans. 1 1996, 2591 - 6
Yao M.-L.Deng M.-Z. Heteroat. Chem. 2000, 11: 380 - 7
Wu J.Liao Y.Yang Z. J. Org. Chem. 2001, 66: 3642 - 8
Wu J.Yang Z. J. Org. Chem. 2001, 66: 7875 - 9
Saleem R.Faizi S.Deeba F.Siddiqui BS.Qazi MH. Planta Med. 1997, 63: 454 - 10
Lin G.-Q.Hong R. J. Org. Chem. 2001, 66: 2877 - 11
Pharkphoom P.Hiroshi N.Wanchai DE. Planta Med. 1998, 64: 774 - 12
Lei J.-G.Lin G.-Q. Chin. J. Chem. 2002, 20: 1263 -
13a
Percec V.Bae J.-Y.Zhao M.Hill DH. J. Org. Chem. 1995, 60: 176 -
13b
Percec V.Bae J.-Y.Hill DH. J. Org. Chem. 1995, 60: 1060 -
13c
Percec V.Bae J.-Y.Zhao M.Hill DH. J. Org. Chem. 1995, 60: 1066 -
13d
Percec V.Golding GM.Smidrkal J.Weichold O. J. Org. Chem. 2004, 69: 3447
References
General Procedure for the Synthesis of 7: To an oven-dried Schlenk flask (25 mL) was charged 4-coumarin compound 3 (0.5 mmol), NiCl2 (PPh3)2 (0.2 equiv), PPh3 (0.4 equiv), zinc dust (2.2 mmol) and dry toluene (3 mL) under argon. The resulting mixture was heated to 90 °C. The aryl halide 5 (0.6 mmol) was then added dropwise through micro-syringe pump over 3 h. After the addition, the reaction mixture was stirred at the same temperature until completion. The reaction mixture was cooled down to r.t., quenched with 5% HCl and diluted by CH2Cl2. The mixture was stirred vigorously at r.t. until the solution was clear. The organic layer was separated and the water layer was extracted with CH2Cl2 (3 × 10 mL). The combined organic layer was washed with sat. aq NaHCO3, brine, and dried over Na2SO4. The solution was concentrated under vacuum; the obtained residue was purified by silica column chromato-graphy to give the corresponding cross-coupling product 7 (selected characterization data of 7 are listed as follows).
15Compound 7c. 1H NMR (300 MHz, CDCl3): d = 9.69 (s, 1 H), 7.86 (m, 1 H), 7.54 (m, 1 H), 7.45 (m, 1 H), 7.22-7.16 (m, 2 H), 7.01 (m, 1 H), 6.40 (s, 1 H), 4.05 (s, 3 H), 3.70 (s, 3 H). MS (EI): m/z (%) = 310 (71) [M+], 295 (100). IR (KBr): 3088, 2947, 2837, 2733, 1729, 1695, 1683, 1604, 1584, 1566 cm-1. Anal. Calcd for C18H14O5: C, 69.67; H, 4.55. Found: C, 69.86; H, 4.57.
16Compound 7f. 1H NMR (300 MHz, CDCl3): d = 8.08 (d, J = 2.1 Hz, 1 H), 7.64 (s, 1 H), 7.54 (d, J = 7.5 Hz, 1 H), 7.51 (d, J = 7.5 Hz, 1 H), 7.42-7.21 (m, 4 H), 6.45 (d, J = 2.1 Hz, 1 H), 3.93 (s, 3 H). 13C NMR (75.5 MHz, CDCl3): d = 175.12, 160.67, 157.84, 154.08, 153.90, 151.45, 148.05, 132.41, 127.02, 124.91, 124.52, 120.90, 120.03, 118.95, 117.70, 117.45, 105.45, 56.28. MS (EI): m/z (%) = 320 (4) [M+], 292 (10.00). IR (KBr): 3078, 2963, 1720, 1649, 1610, 1488, 1446, 1334, 1271 cm-1. HRMS: m/z calcd for C19H12O5: 320.0685; found: 320.0734.
17Compound 7h. 1H NMR (300 MHz, CDCl3): δ = 8.05 (s, 1 H), 7.65 (s, 1 H), 7.55-7.30 (m, 4 H), 7.11 (s, 1 H), 6.42 (s, 1 H), 3.94 (s, 3 H), 2.34 (s, 3 H). 13C NMR (75.5 MHz, CDCl3): δ = 174.84, 160.58, 157.73, 153.66, 151.79, 151.20, 147.65, 133.95, 133.21, 126.31, 124.64, 120.69, 119.76, 118.46, 117.47, 116.90, 105.26, 59.01, 20.91. MS (EI): m/z (%) = 335 (18) [M+ + 1], 334 (78) [M+], 333 (21) [M+ - 1], 306 (100). IR (KBr): 3078, 2959, 2929, 2498, 1719, 1698, 1646, 1618, 1568, 1488, 821 cm-1. HRMS: m/z calcd for C20H14O5: 334.0841; found: 334.0874.
18Compound 7j. 1H NMR (300 MHz, CDCl3): δ = 9.70 (s, 1 H), 7.54-7.30 (m, 5 H), 6.80 (s, 1 H), 6.39 (d, J = 15 Hz, 2 H). MS (EI): m/z (%) = 312 (71) [M+], 269 (100). IR (KBr): 3075, 2913, 2861, 1725, 1682, 1610, 1571, 1504, 1482, 1440, 1369, 1268, 1253 cm-1. HRMS: m/z calcd for C17H9FO5: 312.0434; found: 312.0385.
19Compound 7m. 1H NMR (300 MHz, CDCl3): δ = 10.16 (s, 1 H), 8.09 (d, J = 9.0 Hz, 2 H), 7.89 (d, J = 9.0 Hz, 2 H), 7.74-7.58 (m, 4 H), 7.37 (d, J = 9.3 Hz, 1 H), 7.16 (d, J = 8.7 Hz, 1 H), 6.51 (s, CH, 1 H). MS (EI): m/z (%) = 301 (20) [M+ + 1], 300 (91) [M+], 272 (100). IR (KBr): 1733, 1631, 1601, 1549, 1500, 1470, 1375, 1209 cm-1. HRMS: m/z calcd for C20H12O3: 300.0786; found: 300.0809.